2006 Principal Investigator
A Phase 3, Randomized, Multi-Center, Double-Blind, Placebo-Controlled, Parallel Group Study
Assessing the Safety and Efficacy of XXX Microgranules Oral Suspension in Infants with Symptomatic Gastroesophageal Reflux Disease.
2007 Principal Investigator
A Multicenter, Randomized, Double-Blind Study of the Clinical Outcomes, Safety and Tolerability of Multiple Doses of XXX in Children Ages 1 To 5, With Endoscopically Proven Symptomatic GERD.
2007 Principal Investigator
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Treatment-Withdrawal Study of the Efficacy and Safety of XXX in Infants (1 Through 11 Months)With Symptomatic GERD.
2007 Principal Investigator
A Multicenter, Randomized, Open Label, Single, and Multiple Dose Study of the Safety and Pharmacokinetics of 2 Dose Levels of XXX in Children Aged 1 Through 11 Years with Endoscopically Proven GERD.
2007 Sub- Investigator A Multicenter, Open-Label Pharmacokinetic, Pharmacodynamic, …Clinical Symptoms, and Safety Study of XXX Administered as a Suspension in Neonates and Preterm Infants with a Clinical Diagnosis of Gastroesophageal Reflux Disease.
2008 Principal Investigator A Multicenter, Open-Label, Ascending, Multiple-Dose Study to Assess the Pharmacokinetics, Safety, and Tolerability of XXX in Patients 8-11 Years of Age with Selected Serious Infections.
2009 Principal Investigator A Multi-Center, Double-Blind, Parallel-Group Study to Evaluate Short-Term Safety and Efficacy and Long-term Maintenance of Two Dose Levels of XXX in 1- to 11-Year-Old Pediatric Subjects with Endoscopically Proven GERD.
2010 Principal Investigator A Multi-Center, Double-Blind, Parallel-Group Study to Evaluate Short-Term Safety and Efficacy and Long-term Maintenance of Two Dose Levels of XXX in 0-1 Year-Old Pediatric Subjects with GERD.


Dr. Rima Mustafa Jibaly, MD
0
The iMedixStars rating goes beyond a simple average of reviews. It’s calculated based on various factors, including the quantity, recency, and reliability of the reviews. Read More
Overwiew
Doctor Organizations
- Hurley Medical Center
Doctor Education
Medical School
1989
American University Of Beirut Faculty Of Medicine
Work Place
Memorial Healthcare Gastroenterology
1123 Villa Linde Ct Ste 38
Flint
MI
48532
USA
+19897294232
Specialties
Insurance Plans
- Humana Preferred PPO
- Multiplan PPO
- Humana ChoiceCare Network PPO
- UHC Options PPO
- HAP Preferred PPO
- Aetna Managed Choice POS Open Access
- BCBS MI Blue Care Network HMO Group Enrollees
- BCBS IL PPO
- Aetna Signature Administrators PPO
- PHCS PPO
- PriorityHealth HMO
- Humana Choice POS
- UHC Navigate POS
- Aetna Choice POS II
- UHC Choice Plus POS
- CIGNA PPO
- CIGNA HMO
- PriorityHealth Priority PPO
- BCBS Blue Card PPO
- UHC Navigate HMO
- HAP HMO Full Network
- BCBS MI PPO Plans Group Enrollees
- CIGNA Open Access Plus
- First Health PPO
- Aexcel PPO
- Blue Care Network HMO - Group Enrollees
- Blue Care Network PCP Focus Network HMO
- Blue Cross Premier PPO
- McLaren Health Plan Community
- MEDICA CHOICE WITH UNITEDHEALTHC
- PPO Plans - Group Enrollees
- Priority Health HMO
- UHC NAVIGATE PLUS POS
- UHC Nexus Open Access
- Aetna Elect Choice EPO Open Access
- Aetna Innovation Health Aetna Premier Care Network Plus
- Aetna Open Choice PPO
- BCBS MI Blue Care Network PCP Focus Network HMO
- BCBS MI Blue Cross Preferred
- BCBS MI Blue Cross Premier PPO
- BCBS MI Blue Cross Select
- HAP HMO
- HAP PPO
- Humana / ChoiceCare Network PPO
- Humana/ChoiceCare+ Network PPO
- Medica Choice With UHC
- PHP Exclusive Network
- Physicians Health Plan PPO or EPO
- Physicians Health Plan Sparrow / SPN
- PriorityHealth MyPriority HMO Gold
- PriorityHealth PriorityHMO
- Molina Marketplace MI
- PriorityHealth MyPriority HMO
- Anthem Blue Access PPO
Conditions
- Gastritis and Duodenitis
- Acute Pancreatitis
- Esophagitis
- Gastrointestinal Hemorrhage
- Celiac Disease
- Reviews
- Q&A
0 total
- 5 0 %
- 4 0 %
- 3 0 %
- 2 0 %
- 1 0 %
There are no questions!
Leave a comment